HUMA - Humacyte, Inc.
1.22
-0.010 -0.820%
Share volume: 1,401,485
Last Updated: 05-07-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.02%
PREVIOUS CLOSE
CHG
CHG%
$1.23
-0.01
-0.01%
View ratios
| Fiscal Date | 03-31-2023 | 06-30-2023 | 03-31-2024 | 06-30-2024 | 09-30-2024 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q1 2024 | Q2 2024 | Q3 2024 | |
| Report Date | 05-12-2023 | 08-14-2023 | 05-13-2024 | 08-13-2024 | 11-08-2024 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | nan% | |||
| Operating expenses | 22.512 M | 26.731 M | 26.578 M | 29.499 M | 30.233 M | |
| Selling general and admin | 5.234 M | 6.191 M | 5.314 M | 5.746 M | 7.307 M | |
| Research and development | 17.278 M | 20.540 M | 21.264 M | 23.753 M | 22.926 M | |
| Total expenses | 22.512 M | 26.731 M | 26.578 M | 29.499 M | 30.233 M | |
| 18.74% | -0.57% | 10.99% | 2.49% | |||
| Operating income | -22.512 M | -26.731 M | -26.578 M | -29.499 M | -30.233 M | |
| Ebit | -22.512 M | -26.731 M | -31.111 M | -55.458 M | -37.675 M | |
| Pretax income | -36.969 M | -22.706 M | -31.896 M | -56.663 M | -39.202 M | |
| -38.58% | 40.47% | 77.65% | -30.82% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | -36.969 M | -22.706 M | 0.000 | 0.000 | 0.000 | |
| 38.58% | 100.00% | |||||
| Net income | -36.969 M | -22.706 M | -31.896 M | -56.663 M | -39.202 M | |
| 38.58% | -40.47% | -77.65% | 30.82% |
